Unlocking Cardioprotective Potential of Gut Microbiome: Exploring Therapeutic Strategies

被引:0
|
作者
Qu, Jun [1 ]
Meng, Fantao [2 ]
Wang, Zhen [1 ]
Xu, Wenhao [1 ]
机构
[1] Yantai Yuhuangding Hosp, Dept Internal Med Cardiovasc, Yantai, Shandong, Peoples R China
[2] Linyi Cent Hosp, Dept Internal Med Cardiovasc, Linyi, Shandong, Peoples R China
关键词
Microbiome dysbiosis; probiotics; prebiotics; synbiotics; TMAO inhibitors; atherosclerosis; INTERNATIONAL SCIENTIFIC ASSOCIATION; TRIMETHYLAMINE-N-OXIDE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CHLAMYDIA-PNEUMONIAE; CONSENSUS STATEMENT; HEART-FAILURE; SUPPLEMENTATION; CONSUMPTION; PROBIOTICS;
D O I
10.4014/jmb.2405.05019
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The microbial community inhabiting the human gut resembles a bustling metropolis, wherein beneficial bacteria play pivotal roles in regulating our bodily functions. These microorganisms adeptly break down resilient dietary fibers to fuel our energy, synthesize essential vitamins crucial for our well-being, and maintain the delicate balance of our immune system. Recent research indicates a potential correlation between alterations in the composition and activities of these gut microbes and the development of coronary artery disease (CAD). Consequently, scientists are delving into the intriguing realm of manipulating these gut inhabitants to potentially mitigate disease risks. Various promising strategies have emerged in this endeavor. Studies have evidenced that probiotics can mitigate inflammation and enhance the endothelial health of our blood vessels. Notably, strains such as Lactobacilli and Bifidobacteria have garnered substantial attention in both laboratory settings and clinical trials. Conversely, prebiotics exhibit anti-inflammatory properties and hold potential in managing conditions like hypertension and hypercholesterolemia. Synbiotics, which synergistically combine probiotics and prebiotics, show promise in regulating glucose metabolism and abnormal lipid profiles. However, uncertainties persist regarding postbiotics, while antibiotics are deemed unsuitable due to their potential adverse effects. On the other hand, TMAO blockers, such as 3,3-dimethyl-1-butanol, demonstrate encouraging outcomes in laboratory experiments owing to their anti-inflammatory and tissue-protective properties. Moreover, fecal transplantation, despite yielding mixed results, warrants further exploration and refinement. In this comprehensive review, we delve into the intricate interplay between the gut microbiota and CAD, shedding light on the multifaceted approaches researchers are employing to leverage this understanding for therapeutic advancements.
引用
收藏
页码:2413 / 2424
页数:12
相关论文
共 50 条
  • [41] Rhizosphere microbiome regulation: Unlocking the potential for plant growth
    Luo, Chenghua
    He, Yijun
    Chen, Yaping
    CURRENT RESEARCH IN MICROBIAL SCIENCES, 2025, 8
  • [42] Exploring the Role of Gut Microbiome in Colon Cancer
    Indranil Chattopadhyay
    Ruby Dhar
    Karthikeyan Pethusamy
    Ashikh Seethy
    Tryambak Srivastava
    Ramkishor Sah
    Jyoti Sharma
    Subhradip Karmakar
    Applied Biochemistry and Biotechnology, 2021, 193 : 1780 - 1799
  • [43] Exploring the role of gut microbiome in male reproduction
    Wang, Yan
    Xie, Zuogang
    ANDROLOGY, 2022, 10 (03) : 441 - 450
  • [44] Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
    Bicknell, Brian
    Liebert, Ann
    Borody, Thomas
    Herkes, Geoffrey
    McLachlan, Craig
    Kiat, Hosen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [45] A comprehensive review on the pharmacological role of gut microbiome in neurodegenerative disorders: potential therapeutic targets
    Aziz, Namra
    Wal, Pranay
    Patel, Aman
    Prajapati, Harshit
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (10) : 7307 - 7336
  • [46] Exploring the Role of Gut Microbiome in Colon Cancer
    Chattopadhyay, Indranil
    Dhar, Ruby
    Pethusamy, Karthikeyan
    Seethy, Ashikh
    Srivastava, Tryambak
    Sah, Ramkishor
    Sharma, Jyoti
    Karmakar, Subhradip
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2021, 193 (06) : 1780 - 1799
  • [47] Exploring the early life gut microbiome with MAGIC
    Pasolli, Edoardo
    CELL HOST & MICROBE, 2024, 32 (12) : 2047 - 2049
  • [48] Gut integrity in intensive care: alterations in host permeability and the microbiome as potential therapeutic targets
    Oami, Takehiko
    Shimazui, Takashi
    Yumoto, Tetsuya
    Otani, Shunsuke
    Hayashi, Yosuke
    Coopersmith, Craig M.
    JOURNAL OF INTENSIVE CARE, 2025, 13 (01):
  • [49] Potential therapeutic applications of the gut microbiome in obesity: from brain function to body detoxification
    Choi, Beatrice S. -Y.
    Daoust, Laurence
    Pilon, Genevieve
    Marette, Andre
    Tremblay, Angelo
    INTERNATIONAL JOURNAL OF OBESITY, 2020, 44 (09) : 1818 - 1831
  • [50] Potential therapeutic applications of the gut microbiome in obesity: from brain function to body detoxification
    Béatrice S.-Y. Choi
    Laurence Daoust
    Geneviève Pilon
    André Marette
    Angelo Tremblay
    International Journal of Obesity, 2020, 44 : 1818 - 1831